Cargando…

In silico-based vaccine design against Ebola virus glycoprotein

Ebola virus (EBOV) is one of the lethal viruses, causing more than 24 epidemic outbreaks to date. Despite having available molecular knowledge of this virus, no definite vaccine or other remedial agents have been developed yet for the management and avoidance of EBOV infections in humans. Disclosing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dash, Raju, Das, Rasel, Junaid, Md, Akash, Md Forhad Chowdhury, Islam, Ashekul, Hosen, SM Zahid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367765/ https://www.ncbi.nlm.nih.gov/pubmed/28356762 http://dx.doi.org/10.2147/AABC.S115859

Ejemplares similares

Molecular docking of fisetin with AD associated AChE, ABAD and BACE1 proteins
por: Dash, Raju, et al.
Publicado: (2014)

Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer
por: Dash, Raju, et al.
Publicado: (2015)

Molecular Simulation Studies of 3,3′-Diindolylmethane as a Potent MicroRNA-21 Antagonist
por: Junaid, Md., et al.
Publicado: (2017)

Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics
por: Oany, Arafat Rahman, et al.
Publicado: (2020)

Epitope design of L1 protein for vaccine production against Human Papilloma Virus types 16 and 18
por: Baidya, Sunanda, et al.
Publicado: (2017)

Structural and Dynamic Characterizations Highlight the Deleterious Role of SULT1A1 R213H Polymorphism in Substrate Binding
por: Dash, Raju, et al.
Publicado: (2019)

A Highly Conserved GEQYQQLR Epitope Has Been Identified in the Nucleoprotein of Ebola Virus by Using an In Silico Approach
por: Ali, Mohammad Tuhin, et al.
Publicado: (2015)

Comparative Study of different msDNA (multicopy single-stranded DNA) structures and phylogenetic comparison of reverse transcriptases (RTs): evidence for vertical inheritance
por: Das, Rasel, et al.
Publicado: (2011)

In silico characterization and structural modeling of bacterial metalloprotease of family M4
por: Hasan, Rajnee, et al.
Publicado: (2021)

Acidochromic Behavior of Dibenzylidene Cyclohexanone-Based Bischalcone: Experimental and Theoretical Study
por: Badal, Md Mizanur Rahman, et al.
Publicado: (2020)

Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition
por: Rahman, Md. Mominur, et al.
Publicado: (2021)

Ebola virus: a new concern, its virological characteristics, diagnosis, present condition, and treatment during the ongoing SARS-CoV-2 omicron variant – correspondence
por: Uddin, Md. Jamir, et al.
Publicado: (2023)

Recombinant Antibodies to the Ebola Virus Glycoprotein
por: Panina, A. A., et al.
Publicado: (2017)

An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest
por: Saba, Abdullah Al, et al.
Publicado: (2021)

In silico design and evaluation of novel 5-fluorouracil analogues as potential anticancer agents
por: Chowdhury, Surid Mohammad, et al.
Publicado: (2020)

Prediction of Epitope-Based Peptides for the Utility of Vaccine Development from Fusion and Glycoprotein of Nipah Virus Using In Silico Approach
por: Sakib, M. Sadman, et al.
Publicado: (2014)

Target specific inhibition of West Nile virus envelope glycoprotein and methyltransferase using phytocompounds: an in silico strategy leveraging molecular docking and dynamics simulation
por: Akash, Shopnil, et al.
Publicado: (2023)

An in-silico approach to design potential siRNAs against the ORF57 of Kaposi’s sarcoma-associated herpesvirus
por: Rahman, Anisur, et al.
Publicado: (2021)

Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates
por: Gunn, Bronwyn M., et al.
Publicado: (2023)

In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice
por: Bazhan, Sergei I., et al.
Publicado: (2019)

Implementation of in silico methods to predict common epitopes for vaccine development against Chikungunya and Mayaro viruses
por: Hoque, Hammadul, et al.
Publicado: (2021)

Toremifene interacts with and destabilizes the Ebola virus glycoprotein
por: Zhao, Yuguang, et al.
Publicado: (2016)

A computational approach to design a polyvalent vaccine against human respiratory syncytial virus
por: Moin, Abu Tayab, et al.
Publicado: (2023)

In silico functional and pathway analysis of risk genes and SNPs for type 2 diabetes in Asian population
por: Islam, Md. Numan, et al.
Publicado: (2022)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

In Vivo and In Silico Assessment of Diabetes Ameliorating Potentiality and Safety Profile of Gynura procumbens Leaves
por: Tahsin, Md. Rafat, et al.
Publicado: (2022)

Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccines
por: He, Linling, et al.
Publicado: (2021)

Deciphering Molecular Mechanism of the Neuropharmacological Action of Fucosterol through Integrated System Pharmacology and In Silico Analysis
por: Hannan, Md. Abdul, et al.
Publicado: (2019)

In silico structure analysis and epitope prediction of E3 CR1-beta protein of Human Adenovirus E for vaccine design
por: Patwary, Noman Ibna Amin, et al.
Publicado: (2016)

Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum
por: Bhattacharyya, Suchita, et al.
Publicado: (2011)

The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo
por: Groseth, Allison, et al.
Publicado: (2012)

Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism
por: Vande Burgt, Nathan H., et al.
Publicado: (2015)

Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein
por: Rodríguez-Martínez, Luis Mario, et al.
Publicado: (2015)

The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells
por: Edri, Avishay, et al.
Publicado: (2018)

Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
por: Bhatia, Bharti, et al.
Publicado: (2021)

RLLB/Alb ratio: a promising noninvasive diagnostic marker in assessing esophageal varices in cirrhotic patients
por: Chowdhury, Md Faisal Fahad, et al.
Publicado: (2022)

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells
por: Cai, Yingyun, et al.
Publicado: (2021)

Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
por: Paparisto, Ermela, et al.
Publicado: (2021)

Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone
por: Manno, Daniela, et al.
Publicado: (2022)

In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
por: Rahman, Md. Mominur, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jh0lgme0h6ubd83bq401mu1kck